Navigation Links
Physician Referrals Limiting Treatment of the Venous System
Date:8/25/2010

TORONTO, Aug. 25 /PRNewswire/ -- Millennium Research Group (MRG), the global authority on medical technology market intelligence, finds that although venous procedures are set to grow by more than 10% through 2013, a lack of awareness among referring physicians is a major roadblock in increased interventions in the venous system.

Despite this trend, specialists are increasingly adopting new technologies, with 55% of respondents having used pharmacomechanical thrombectomy systems for deep vein thrombosis removal, and 66% performing venous stenting on a regular basis.  The venous system has recently been gaining exposure as an under treated area of the human vasculature. New evidence of clinical success has spurred a trend towards increasingly aggressive interventions both for acute and chronic venous disease. A major contributing factor was the 2008 Surgeon General's Call to Action on Deep Vein Thrombosis and Pulmonary Embolism, but the rise of arterial stents in the venous system has also played a significant role.

"Respondents identified increased education among primary care practitioners as the most important factor that would drive venous stenting," says Stephanie LaBelle, Manager of the Cardiovascular division at MRG. "A third of respondents were unaware of the practice of venous stenting, and 40% do not refer patients for the procedure."

MRG's new Physician Forum publication, Venous Interventions: The Rise of Venous Stenting and Aggressive Deep Vein Thrombosis Treatment is based on 98 US specialists who treat deep vein diseases, and 78 primary care practitioners who refer these patients.  The publication investigates the changing dynamics of the venous interventional market with a specific focus on acute deep vein thrombosis treatment, and the treatment of obstructive chronic deep vein disease with venous stents.

WebinarOn Wednesday September 8, at 11:00 am eastern time, MRG is offering a complimentary webinar with the author of Venous Interventions: The Rise of Venous Stenting and Aggressive Deep Vein Thrombosis Treatment, Manager of the Cardiovascular division, Stephanie LaBelle.  Ms. LaBelle will present an overview of findings from MRG's new study and host a brief Q&A session.  Please contact Amy Krohn at 416-364-7776 ext. 101 or akrohn@mrg.net to register.

About Physician ForumPhysician Forum assesses physician opinions to get a sense of how market dynamics will shift in response to major events or trends. Publications feature direct feedback from relevant specialists and insight into the impact of events on specific markets. Publications are based on physician interviews and stakeholder surveys.

About Millennium Research GroupMillennium Research Group (www.MRG.net), a Decision Resources, Inc. company (www.DecisionResourcesInc.com), is the global authority on medical technology market intelligence and the leading provider of strategic information to the healthcare sector. The company provides specialized industry expertise through multiclient market research, ongoing Marketrack™ projects, customer loyalty tracking, facility-level procedure forecasting, and customized solutions.

About Decision Resources, Inc.Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information, and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions.

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.For more information, contact:Amy KrohnMillennium Research Group416-364-7776 ext. 101akrohn@mrg.netChris ComfortDecision Resources Inc.781-993-2597ccomfort@dresources.com
'/>"/>

SOURCE Millennium Research Group
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Protectus Medical Devices Appoints as Medical Director a Physician Surgeon With 20-Year Involvement in Senior Level Monitoring of Pharmaceutical and Medical Devices
2. North American Spine Welcomes Robert R. Bulger, M.D. to Dallas Physician Group
3. Manhattans Physicians Group Selects ITelagen for Hosting and Management of EHR
4. GHX to Present Strategies to Optimize Procurement, Especially of Physician Preference Items, at Annual AHRMM Conference
5. Millennium Laboratories, Inc. Urges Medicare to Reconsider the 2010 Physician Reimbursement for Point-of-Care Urine Drug Screen Devices
6. Education Tactics for Thought Leaders, Physicians, Patients and Payers to Support Successful Oncology Product Launches
7. Hudson Valley Physician Testifies Before House Health Subcommittee Tuesday About Incentives for Adoption of Health Information Technology
8. MedWest Health System Selects Allscripts Electronic Health Record and Practice Management for Employed Physicians
9. Physician Outraged by Medicare Power Wheelchair Documentation Policy
10. Sharp HealthCare Selects Allscripts Community Record to Deliver End-to-End Health Information Connectivity for San Diego Physicians and Hospitals
11. Group Practice Forum Launches Fromer-GPF Patient Journey Providing Physicians with Simple Solutions to Improve Patient Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2017)... Md. , Jan. 24, 2017   Intrexon Corporation ... engineering and industrialization of biology to improve the quality of ... has entered into a definitive agreement to acquire GenVec, ... and pioneer in the development of AdenoVerse™ gene delivery technology.  ... GenVec,s expertise in adenoviral vectors and cGMP drug product manufacturing ...
(Date:1/24/2017)... , Jan. 24, 2017   QR ... biopharmaceutical company developing novel therapies for the treatment ... announced the appointment of four world-class key opinion ... new appointments join QR Pharma,s previous roster of ... and direction to support the development of the ...
(Date:1/24/2017)... Research and Markets has announced the addition of the "Optogenetics ... report to their offering. ... Global Optogenetics Market is poised to grow at ... approximately $76.24 million by 2025. Some of the prominent ... using optogentic techniques for neurosciences, quick growth ultrafast laser tools technology, ...
Breaking Medicine Technology:
(Date:1/24/2017)... ... January 24, 2017 , ... The health insurance industry is ... (AEP) and the Open Enrollment Period (OEP). 2016 was no exception. If anything, ... witnessing higher deductibles, rising premiums, and few choices with their insurance, which is ...
(Date:1/24/2017)... ... , ... The Cruise Web Inc. was recognized today as Northeast ... Annual MSC True Partnerships’ Awards. , The 2016 MSC True Partnerships Awards are ... on overall business growth in revenue and guests and continuous partnership support and innovative ...
(Date:1/24/2017)... ... January 24, 2017 , ... OMI Industries, a worldwide leader ... distribution partnership with Byers Scientific & Manufacturing , a leading designer, engineer ... agreement, OMI Industries formulated a special version of Ecosorb® for Byers Scientific & ...
(Date:1/24/2017)... Hill, N.C. (PRWEB) , ... January 24, 2017 ... ... Trump Administration is the focus of a new report from the Frank ... Kenan-Flagler Business School. , Influential business leaders, academics and policy makers identified concrete ...
(Date:1/24/2017)... ... January 24, 2017 , ... Date aired: January 23, 2017 ... the nation’s foremost water advocate and host of the nationally syndicated The Sharon ... America, once again welcomed one of her favorite guests and colleagues, Dr. Gerald ...
Breaking Medicine News(10 mins):